✨ Your Portfolio is fetched and updated from zerodha.
Micro Hospitals

Aspira Pathlab & Diagnostics Ltd.

ASPIRA

Market Cap
₹71 Cr.
P/E
83.68

Aspira Pathlab & Diagnostics Ltd.

  • Aspira Pathlab&Diagn
  • Constronics Infra
  • NG Industries
FAQs on Aspira Pathlab & Diagnostics Ltd. Shareprice

Aspira Pathlab&Diagn has given better returns compared to its competitors.
Aspira Pathlab&Diagn has grown at ~124.22% over the last 1yrs while peers have grown at a median rate of 20.8%

Yes, Aspira Pathlab&Diagn is expensive.
Latest PE of Aspira Pathlab&Diagn is 83.68, while 3 year average PE is 13.75.
Also latest EV/EBITDA of Aspira Pathlab&Diagn is 29.62 while 3yr average is 22.62.

View FAQ's On Business
Growth Table
  • Aspira Pathlab & Diagnostics Ltd.
  • Constronics Infra
  • NG Industries
Balance Sheet
  • Aspira Pathlab & Diagnostics Ltd.
  • Constronics Infra
  • NG Industries
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Aspira Pathlab & Diagnostics Ltd.
  • Constronics Infra
  • NG Industries
Cash Flow
  • Aspira Pathlab & Diagnostics Ltd.
  • Constronics Infra
  • NG Industries
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Aspira Pathlab & Diagnostics Ltd.
  • Constronics Infra
  • NG Industries
Quarterly Results
  • Aspira Pathlab & Diagnostics Ltd.
  • Constronics Infra
  • NG Industries
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Aspira Pathlab & Diagnostics Ltd. Financials

Balance sheet of Aspira Pathlab&Diagn is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Aspira Pathlab&Diagn is increasing.
Latest debt of Aspira Pathlab&Diagn is -₹1.27 Crs as of Sep-24.
This is greater than Mar-24 when it was -₹1.66 Crs.

The profit is oscillating.
The profit of Aspira Pathlab&Diagn is ₹0.84 Crs for TTM, -₹2.67 Crs for Mar 2024 and -₹0.09 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aspira Pathlab&Diagn latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech